Interferon regulatory factor 4 (IRF4) was found to be highly silenced by DNA hypermethylation in both gastric cancers and gastric mucosa from cancer patients, which suggested that IRF4 hypermethylation may be a useful molecular marker for diagnosing recurring gastric cancer22. Here, IRF4 is linked to cancer.